Global pharma giants Pfizer and Mylan have announced that they are combining two of their businesses. Pfizer will spin off its generics drug business and combine it with Mylan. Mylan is a company with which Biocon has a tie up. Kiran Mazumdar Shaw, CMD of Biocon assessed the impact on Indian pharma.
